Otani et al. [60] studied the role of neurogenic locus notch homolog protein 1 (NOTCH 1) in signaling an immune evasion with post-oHSV (oncovirus-herpes simplex virus) viral therapy in patients with GBM. Here, NOTCH1 is linked to glioblastoma.